Variables | Coefficient | P value |
---|---|---|
Included in the final regression model | ||
PaCO2 changes | 0.018 (0.011‒0.025) | < 0.001 |
Intraoperative Plasma-Lyte 148 administration volume | 0.061 (0.031‒0.091) | < 0.001 |
Type II diabetes mellitus | 0.154 (0.023‒0.284) | 0.021 |
Excluded in the final regression model | ||
Age | 0.084 | 0.464 |
American Society of Anesthesiologists status | 0.029 | 0.683 |
Body mass index | 0.046 | 0.703 |
Smoking history | − 0.008 | 0.889 |
Obstructive lung disease | 0.058 | 0.348 |
Coronary artery disease | − 0.041 | 0.464 |
Hypertension | 0.014 | 0.847 |
Renal disease (creatinine > 120 umol/L) | − 0.102 | 0.058 |
Hepatic disease (bilirubin > 50 umol/L) | 0.07 | 0.199 |
Emergency surgery | − 0.036 | 0.497 |
Duration of surgical procedure | 0.156 | 0.235 |
Corrected ARISCAT score | 0.082 | 0.475 |